Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Theresa Luu

Thoracic Surgery (Cardiothoracic Vascular Surgery) Marietta, GA Medical Doctor

NPI 1831377092 CMS profile 37600

61 Whitcher St Ne, Suite 4120, Marietta, GA 30060

Open in the dashboard

General payments

$32,454

375 records reported · program years 2019–2025

Research payments

$5,950

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$5,466 paid to institutions, not to them · program year 2025

Through program year 2025, Theresa Luu of Marietta, GA is reported in the CMS Open Payments database as having received $32,454 across 375 general payments and $5,950 in research payments paid to them. Separately, studies naming them as principal investigator received $5,466 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 87th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,221 38
2024 General $3,994 70
2023 General $13,353 97
2022 General $3,147 61
2022 Research $5,950 1
2021 General $4,903 38
2020 General $935 30
2019 General $3,900 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Theresa Luu
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Theresa Luu were reported at $2,221. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Theresa Luu Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $3,900 $886 $178–$3,167 $163
2020 $935 $341 $108–$1,605 $114
2021 $4,903 $453 $125–$1,886 $132
2022 $3,147 $695 $180–$2,566 $149
2023 $13,353 $745 $205–$2,662 $160
2024 $3,994 $799 $214–$2,967 $164
2025 $2,221 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Atricure, Inc. $18,389 161 payments
  2. Abbott Laboratories $6,719 77 payments
  3. Medtronic, Inc. $2,788 34 payments
  4. Medtronic Vascular, Inc. $1,356 11 payments
  5. Abiomed $768 11 payments
  6. Boston Scientific Corporation $568 7 payments
  7. Edwards Lifesciences Corporation $409 17 payments
  8. Maquet Cardiovascular U.S. Sales, L.L.C. $401 13 payments
  9. Lsi Solutions Inc $193 4 payments
  10. AngioDynamics, Inc. $136 4 payments
  11. Other $727 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $12,763 335 payments
  2. Travel and Lodging $9,897 33 payments
  3. Consulting Fee $9,600 5 payments
  4. Education $193 2 payments
Products named General payments · program years 2019–2025
  1. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $13,231 67 payments
  2. HeartMate Touch $3,600 4 payments
  3. ATRICLIP LAA EXCLUSION SYSTEM $2,519 38 payments
  4. Octopus $1,997 15 payments
  5. SYNERGY ABLATION SYSTEM $1,631 39 payments
  6. HeartWare HVAD $1,311 7 payments
  7. THORATEC HEARTMATE 3 LVAS IMPLANT KIT Heart failure $1,071 29 payments
  8. AtriCure cryoICE cryoSPHERE Cryoablation System $1,051 22 payments
  9. THORATEC HEARTMATE 3 LVAS IMPLANT KIT Structural Heart $1,004 9 payments
  10. Impella $746 10 payments
  11. Other $5,734 159 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $5,950 1 payment

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$181,361

Medicare's payments for the services billed

Medicare patients

243

Average age 75

Services billed

456

94 women, 149 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 60%
Atrial fibrillation 52%
Arthritis 47%
Diabetes 41%
Chronic kidney disease 33%
Depression 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

376 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record